Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Save this search Download search results Subscribe to news feed Your filters: cql: keyword exact "Checkpoint inhibitors" Add to list Journal Article A1 Immune checkpoint inhibitors in treatment of soft-tissue sarcoma : a systematic review and meta-analysis Michael Saerens (UGent) , Nele Brusselaers (UGent) , Sylvie Rottey (UGent) , Alexander Decruyenaere (UGent) , David Creytens (UGent) and Lore Lapeire (UGent) (2021) EUROPEAN JOURNAL OF CANCER. 152. p.165-182 Add to list Journal Article A1 Nivolumab-induced immune-mediated colitis : an ulcerative colitis look-alikereport of new cases and review of the literature Fiorella Canete, Miriam Manosa, Triana Lobatón Ortega (UGent) , Francisco Mesonero, Iago Rodriguez-Lago, Eduard Cabre, Jose L. Cabriada, Antonio Lopez-Sanroman and Eugeni Domenech (2019) INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 34(5). p.861-865 Add to list Journal Article A2 open access Psoriasis vulgaris exacerbation during treatment with a PD-1 checkpoint inhibitor : case report and literature review Marlies De Bock, Eva Hulstaert (UGent) , Vibeke Kruse (UGent) and Lieve Brochez (UGent) (2018) CASE REPORTS IN DERMATOLOGY. 10(2). p.190-197 Add to list Journal Article A1 Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma Nora Sundahl (UGent) , Katrien De Wolf, Vibeke Kruse (UGent) , Annabel Meireson (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Mireille Van Gele (UGent) , Reinhart Speeckaert (UGent) , Benjamin Hennart, Lieve Brochez (UGent) , et al. (2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.906-915 Add to list Journal Article A1 Pembrolizumab for the treatment of bladder cancer Nora Sundahl (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) and Piet Ost (UGent) (2018) EXPERT REVIEW OF ANTICANCER THERAPY. 18(2). p.107-114 Add to list Journal Article A1 A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Geneviève Garcin, Jennyfer Bultinck (UGent) , Franciane Paul, Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yann Bordat, Dominiek Catteeuw (UGent) , Lode De Cauwer (UGent) , et al. (2017) ONCOIMMUNOLOGY. 7(3).